Prognostic Impact of Iron Deficiency in New-Onset Chronic Heart Failure: Danish Heart Failure Registry Insights
ESC Heart Failure · 2025
DOI: 10.1002/ehf2.15149 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Abdullahi Ahmed Mohamed und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte Hospital, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Heart Failure, Registries, Anemia, Iron-Deficiency, Iron Deficiencies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte Hospital.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Aims
Iron deficiency (ID) is prevalent in chronic heart failure (HF) but lacks a consensus definition. This study evaluates the prevalence and the prognostic impact of ID using different criteria on all-cause and cardiovascular mortality, as well as first hospitalization for HF in patients with new-onset chronic HF.
Methods
In this nationwide registry-based cohort, we explored four definitions of ID: the current European Society of Cardiology (ESC) guidelines [ferritin <100 ng/mL or ferritin 100–299 ng/mL and transferrin saturation (TSAT) <20%], ferritin level <100 ng/mL, TSAT < 20% and serum iron ≤13 μmol/L. Patients were identified through the Danish Heart Failure Registry.
Results
Of 9477 new-onset chronic HF patients registered in the Danish Heart Failure Registry from April 2003 to December 2019, we observed ID prevalence rates ranging from 35.8% to 64.3% depending on the ID definition used. Among patients with ID defined by iron ≤13 μmol/L or TSAT < 20%, 26% and 15.5%, respectively, did not meet the ESC guidelines definition for ID. Conversely, 11% of patients meeting the ESC criteria exhibited serum iron >13 μmol/L and TSAT > 20%. Regardless of anaemia status, ID defined by TSAT < 20% or serum iron ≤13 μmol/L was associated with all-cause mortality [non-anaemic, hazard ratio (HR): 1.57, 95% confidence interval (CI): 1.30–1.89 and HR: 1.47, 95% CI: 1.24–1.73; anaemic, HR: 1.22, 95% CI: 1.07–1.38 and HR: 1.25, 95% CI: 1.09–1.44, respectively] and cardiovascular mortality (non-anaemic, HR: 2.21, 95% CI: 1.59–3.06 and HR: 1.47, 95% CI: 1.12–1.95; anaemic, HR: 1.37, 95% CI: 1.11–1.69 and HR: 1.28, 95% CI: 1.02–1.61, respectively), as well as increased risk of first hospitalization for HF (non-anaemic, HR: 1.28, 95% CI: 1.09–1.1.50 and HR: 1.27, 95% CI: 1.10–1.46; anaemic, HR: 1.25, 95% CI: 1.08–1.44 and HR: 1.22, 95% CI: 1.05–1.42, respectively). ID defined by ESC guidelines was associated with all-cause and cardiovascular mortality only in non-anaemic patients (HR: 1.41, 95% CI: 1.18–1.1.70 and HR: 1.58, 95% CI: 1.18-2.12.). Furthermore, the ESC guideline definition was associated with increased risk of first hospitalization for HF, regardless of anaemia status (non-anaemic, HR: 1.26, 95% CI: 1.08–1.1.47; anaemic, HR: 1.34, 95% CI: 1.17–1.53).
Conclusions
ID, when defined by TSAT < 20% or serum iron ≤13 μmol/L, is associated with increased risk of all-cause and cardiovascular mortality, as well as first hospitalization for HF in patients with new-onset chronic HF, regardless of anaemia status. Conversely, ID defined as ESC guidelines is associated with all-cause and cardiovascular mortality only in non-anaemic patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte Hospital, Copenhagen, Denmark.
- Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Cardiology, Copenhagen University Hospital - Nordsjællands Hospital, Hillerød, Denmark.
- Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
- Department of Cardiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- Steno Diabetes Center Copenhagen, Copenhagen, Denmark.
Förderung
- Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte Hospital
Zitieren
APA
Mohamed, A. A., Christensen, D. M., Mohammad, M., Torp-Pedersen, C., Køber, L., Fosbøl, E. L., Biering-Sørensen, T., Hansen, M. L., Malik, M. E., Nouhravesh, N., Anderrson, C., Schou, M., & Gislason, G. (2025). Prognostic Impact of Iron Deficiency in New-Onset Chronic Heart Failure: Danish Heart Failure Registry Insights. ESC Heart Failure. https://doi.org/10.1002/ehf2.15149
Vancouver
Mohamed AA, Christensen DM, Mohammad M, Torp-Pedersen C, Køber L, Fosbøl EL, et al. Prognostic Impact of Iron Deficiency in New-Onset Chronic Heart Failure: Danish Heart Failure Registry Insights. ESC Heart Failure. 2025. doi:10.1002/ehf2.15149
BibTeX
@article{Mohamed2025,
author = {Mohamed, Abdullahi Ahmed and Christensen, Daniel Mølager and Mohammad, Milan and Torp-Pedersen, Christian and Køber, Lars and Fosbøl, Emil Loldrup and Biering-Sørensen, Tor and Hansen, Morten Lock and Malik, Mariam Elmegaard and Nouhravesh, Nina and Anderrson, Charlotte and Schou, Morten and Gislason, Gunnar},
title = {Prognostic Impact of Iron Deficiency in New-Onset Chronic Heart Failure: Danish Heart Failure Registry Insights},
journal = {ESC Heart Failure},
year = {2025},
doi = {10.1002/ehf2.15149}
}
EUVIMED